Portal
SPRAVATO (esketamine) Treatment
When Depression Hasn’t Responded to Traditional Treatment, There Is Still Hope
At Mindville, we understand how discouraging it can feel to live with depression that doesn’t improve despite trying multiple medications or therapy approaches. If you’ve been doing everything asked of you and still don’t feel like yourself, you are not alone — and you are not out of options.
We offer SPRAVATO (esketamine) treatment as part of our integrative mental health approach for individuals with treatment-resistant depression.
What Is SPRAVATO (esketamine)?
SPRAVATO (esketamine) is an FDA-approved medication for adults with treatment-resistant depression. It works differently from traditional antidepressants and targets neural pathways involved in mood, cognition, and emotional processing.
Unlike medications that can take weeks to show effect, SPRAVATO (esketamine) may provide more rapid relief for some individuals — particularly those who have not responded adequately to standard treatments.
SPRAVATO (esketamine) is administered as a nasal spray in a monitored clinical setting, in combination with an oral antidepressant.
Who May Benefit from SPRAVATO (esketamine) Treatment
SPRAVATO (esketamine) may be appropriate if you:
- Have depression that has not improved after trying multiple antidepressants
- Feel emotionally numb, stuck, or hopeless despite ongoing care
- Experience significant impairment in daily functioning
- Are seeking evidence-based options beyond traditional medication adjustments
- Want care that is thoughtful, structured, and closely monitored
A comprehensive evaluation is required to determine whether SPRAVATO (esketamine) is an appropriate and safe option for you.
Our Integrative, Supportive Approach
At Mindville, SPRAVATO (esketamine) is not offered as a standalone solution. We believe meaningful healing happens when innovative treatments are combined with individualized, compassionate care.
Your treatment plan may include:
- Thorough psychiatric evaluation
- Thoughtful medication management
- Ongoing monitoring and support
- Integration of lifestyle and mental health strategies
- Collaboration around your personal goals and values
Throughout treatment, you are supported in a calm, respectful environment where safety, dignity, and connection matter.
What to Expect During Treatment
SPRAVATO (esketamine) is administered in-office under medical supervision
Each session includes a monitoring period for safety and comfort
Treatment occurs on a structured schedule, especially during the initial phase
We closely track symptoms, response, and overall well-being
Scheduling
Hours of Operation
- Monday
- 7 AM – 7 PM
- Friday
- 7 AM – 7 PM
- Saturday
- 7 AM – 7 PM
* Sessions are scheduled by appointment only to ensure proper medical supervision.
Our team remains actively involved before, during, and after each session to ensure you feel informed, supported, and cared for.
A Path Forward
For many individuals, treatment-resistant depression can create a sense of hopelessness or self-blame. At Mindville, we approach this differently.
Needing advanced treatment does not mean you have failed — it means your brain may need a different kind of support.
SPRAVATO (esketamine) treatment offers a science-backed option that, when thoughtfully integrated into care, may help restore hope, clarity, and momentum.
Is SPRAVATO (esketamine) Right for You?
SPRAVATO (esketamine) treatment may be a good fit if you:
- Have not found adequate relief with traditional treatments
- Want an integrative, closely monitored approach
- Value personalized care over one-size-fits-all solutions
- Are ready to explore innovative options with professional guidance
If you’re ready to learn whether SPRAVATO (esketamine) could be part of your healing journey, Mindville is here to help.
Frequently Asked Questions
Insurance coverage for SPRAVATO (esketamine) varies by plan. Many commercial insurance plans and some government plans provide coverage for FDA-approved SPRAVATO (esketamine) treatment when medical criteria are met. Our office assists with benefits verification and prior authorization whenever possible and will review coverage details with you before treatment begins.
If insurance coverage is limited or unavailable, we can discuss self-pay options and expected costs transparently.
SPRAVATO (esketamine) is FDA-approved and has been studied extensively for treatment-resistant depression. At Mindville, safety is a priority.
- Treatment is provided in-office under medical supervision
- Vital signs and clinical response are monitored during each session
- Patients remain on-site for observation following administration
Most side effects are temporary and may include dissociation, dizziness, nausea, or changes in blood pressure. These effects typically resolve within hours. A comprehensive evaluation is completed to ensure SPRAVATO (esketamine) is an appropriate and safe option for you.
Costs depend on insurance coverage, copays, deductibles, and whether self-pay is required. We believe in transparency and will review anticipated costs with you before starting treatment so there are no surprises.
Our team is happy to answer financial questions and help you understand your options.
SPRAVATO (esketamine) treatment follows a structured schedule:
- Initial phase typically involves two sessions per week for several weeks
- Each visit lasts approximately 2–3 hours, including monitoring time
- Maintenance frequency is individualized based on response
Because SPRAVATO (esketamine) can temporarily affect alertness, patients must arrange transportation home after each session and should not drive or return to work the same day.
Request a Consultation
To schedule an evaluation or learn more about SPRAVATO (esketamine) treatment at Mindville, please contact our office or request an appointment through our website.